ClassID:

109145

C12N2310/14 - page 13 - CPC Classification

Classification description:

Structure or type of the nucleic acid; Type of nucleic acid interfering N.A.

Recent Application in this class:
#3601
20190106707
2019-04-11

Compositions and methods for inducing resistance to soybean cyst nematode via RNAi

#3602
20190106700
2019-04-11

siRNA And Their Use In Methods And Compositions For Inhibiting The Expression Of The ORAI1 Gene

#3603
20190106699
2019-04-11

siRNA targeting LDHA

#3604
20190106697
2019-04-11

Inhibition Of Lactate Transporters For Use In The Treatment Of Inflammatory Diseases

#3605
20190106694
2019-04-11

GNAQ targeted dsRNA compositions and methods for inhibiting expression

#3606
20190106503
2019-04-11

Targeting metastasis stem cells through a fatty acid receptor (CD36)

#3607
20190106452
2019-04-11

RNA nanoparticles for brain tumor treatment

#3608
20190106379
2019-04-11

NOVEL CYCLIC CATIONIC LIPIDS AND METHODS OF USE

#3609
20190105395
2019-04-11

CYTOCOMPATIBLE HYDROGELS FOR ENCAPSULATION OF CELLS

#3610
20190105347
2019-04-11

Use of PLA2G5-deficient suppressive macrophages in suppression of inflammation

#3611
20190105341
2019-04-11

Compositions and Methods for Treating Alzheimer's Disease and Other Tauopathies

#3612
20190105271
2019-04-11

Nanoparticle-induced fusogenicity between liposome and endosome membranes for targeted delivery through endosomal escape

#3613
20190100769
2019-04-04

MASSIVELY PARALLEL COMBINATORIAL GENETICS FOR CRISPR

#3614
20190100760
2019-04-04

Methods and compositions for treating atherosclerosis

#3615
20190100759
2019-04-04

Compositions and methods for treating beta-hemoglobinopathies

#3616
20190100757
2019-04-04

Conserved HBV and HCV sequences useful for gene silencing

#3617
20190099487
2019-04-04

METHODS OF USING INTERLEUKIN-10 FOR TREATING DISEASES AND DISORDERS

#3618
20190099453
2019-04-04

Medicament for liver regeneration and for treatment of liver failure

#3619
20190094229
2019-03-28

METHODS OF DIAGNOSING, CLASSIFYING AND TREATING ENDOMETRIAL CANCER AND PRECANCER

#3620
20190094207
2019-03-28

Screening method of anticancer agent focused on function of HP1 and evaluation system

#3621
20190093175
2019-03-28

cgb2 And cgb1 Genes; Diagnosis, Monitoring And Treatment Of Cancer

#3622
20190093171
2019-03-28

Mutant genes related to drug resistance and relapse of acute lymphoblastic leukaemia and a use thereof

#3623
20190093129
2019-03-28

Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

#3624
20190093111
2019-03-28

AAV vectors for treatment of dominant retinitis pigmentosa

#3625
20190093110
2019-03-28

System for the biocontrol of disease-transmitting mosquitoes and their eggs using horizontally transferable symbiotic bacteria to deliver pathogen specific interfering RNA polynucleotides

#3626
20190093109
2019-03-28

Compositions and methods to promote bone formation and their uses including for the treatment of cancer

#3627
20190093108
2019-03-28

Methods and compositions for increased double stranded RNA production

#3628
20190091344
2019-03-28

Amphipathic peptide

#3629
20190091265
2019-03-28

MEDICAMENT FOR LIVER REGENERATION AND FOR TREATMENT OF LIVER FAILURE

#3630
20190091234
2019-03-28

GAMMA-SECRETASE INHIBITION REDUCE APOC3 LEVELS AND PLASMA TRIGLYCERIDES

#3631
20190091225
2019-03-28

Antihelminthic medications for pathogenic nematodes

#3632
20190091220
2019-03-28

TARGETING PARP1 FOR TREATMENT OF TSC AND CANCERS

#3633
20190091160
2019-03-28

Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells

#3634
20190091150
2019-03-28

POROUS NANOPARTICLE-SUPPORTED LIPID BILAYERS (PROTOCELLS) FOR TARGETED DELIVERY AND METHODS OF USING SAME

#3635
20190085359
2019-03-21

Bio-production of lentiviral vectors

#3636
20190085336
2019-03-21

Treatment and diagnosis of inflammatory disorders

#3637
20190085335
2019-03-21

In-vitro induction of adult stem cell expansion and derivation

#3638
20190085332
2019-03-21

DNA aptamers specific to CD2000R1 and their therapeutic uses

#3639
20190085331
2019-03-21

Defined multi-conjugate oligonucleotides

#3640
20190085329
2019-03-21

RNA-directed DNA cleavage by the Cas9-crRNA complex

#3641
20190085328
2019-03-21

In vivo gene silencing by chemically modified and stable siRNA

#3642
20190085324
2019-03-21

Assays for massively combinatorial perturbation profiling and cellular circuit reconstruction

#3643
20190085093
2019-03-21

Composition for regulating cell division comprising FCHO1 modulator, and method for regulating cell division using same

#3644
20190085012
2019-03-21

5′-cyclo-phosphonate modified nucleotides

#3645
20190084965
2019-03-21

Amine cationic lipids and uses thereof

#3646
20190083523
2019-03-21

Methods and compositions for the activation of gamma-delta T-cells

#3647
20190078089
2019-03-14

RNAi agents and compositions for inhibiting expression of angiopoietin-like 3 (ANGPTL3), and methods of use

#3648
20190078088
2019-03-14

RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (APOC3)

#3649
20190078086
2019-03-14

Methods and compositions to treat drug-induced diseases and conditions

#3650
20190077879
2019-03-14

Conjugates enhancing total cellular accumulation

#3651
20190076543
2019-03-14

Method of treating cancer by using siRNA nanocomplexes

#3652
20190076457
2019-03-14

Nanoparticle to target cancer

#3653
20190071690
2019-03-07

COMPOSITIONS AND METHODS FOR INSECTICIDAL CONTROL OF STINKBUGS

#3654
20190071679
2019-03-07

ANTI-TUMOR THERAPY

#3655
20190071676
2019-03-07

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

#3656
20190071671
2019-03-07

Therapeutic for treatment of diseases including the central nervous system

#3657
20190071670
2019-03-07

Methods Of Treatment For Alpha-1 Antitrypsin Deficiency

#3658
20190071669
2019-03-07

LIPID ENCAPSULATING INTERFERING RNA

#3659
20190070314
2019-03-07

Nano/micromotors for active and dynamic intracellular payload delivery

#3660
20190070304
2019-03-07

Biodegradable vectors for efficient RNA delivery

#3661
20190070211
2019-03-07

Niacinamide (NAM) in ischemic tissue injury

#3662
20190070180
2019-03-07

Compositions and methods for the treatment of a beta-catenin-associated disease or disorder

#3663
20190064149
2019-02-28

Cancer examination method and examination kit

#3664
20190062790
2019-02-28

METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION

#3665
20190062786
2019-02-28

Methods and compositions for the activation of gamma-delta T-cells

#3666
20190062782
2019-02-28

Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger RNA

#3667
20190062754
2019-02-28

5-halouracil-modified microRNAs and their use in the treatment of cancer

#3668
20190062751
2019-02-28

Tumor cell malignant transformation suppressor and anti-tumor agent

#3669
20190062749
2019-02-28

SIRNA, PHARMACEUTICAL COMPOSITION AND CONJUGATE WHICH CONTAIN SIRNA, AND USES THEREOF

#3670
20190062748
2019-02-28

Polyconjugates for Delivery of RNAi triggers to Tumor Cells In Vivo

#3671
20190062747
2019-02-28

Polypeptide inhibitors of SMAD3 polypeptide activities

#3672
20190062746
2019-02-28

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

#3673
20190062744
2019-02-28

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

#3674
20190062738
2019-02-28

Method and System for the Diagnosis, Prevention or Treatment of Alzheimer s and Related Disease by Measuring, Inhibiting or Arresting Amyloid Plaque Development

#3675
20190062727
2019-02-28

Cancer treatment through RLIP76 partial depletion

#3676
20190062697
2019-02-28

Cell Differentiation Marker and its Uses

#3677
20190062437
2019-02-28

Nucleic acid-polypeptide compositions and uses thereof

#3678
20190062436
2019-02-28

Nucleic acid-polypeptide compositions and uses thereof

#3679
20190062384
2019-02-28

NOVEL BT TOXIN RECEPTORS AND METHODS OF USE

#3680
20190060488
2019-02-28

Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated to a lipophilic moiety

#3681
20190060349
2019-02-28

TLX and MIR-219 as potential therapeutic targets for neurodevelopmental disorders

#3682
20190060347
2019-02-28

Microbubble complexes and methods of use

#3683
20190060324
2019-02-28

POLYNUCLEOTIDE-POLY(DIOL) CONJUGATES, PROCESS OF PREPARATION AND USES THEREOF

#3684
20190060239
2019-02-28

Technology for the Preparation of Microparticles

#3685
20190059364
2019-02-28

RNAi FOR CONTROL OF PHLOEM SAP-FEEDING INSECTS IN CROP PLANTS

#3686
20190055565
2019-02-21

Prevention, diagnosis and treatment of cancer overexpressing GPR160

#3687
20190055563
2019-02-21

POLYMERASE Q AS A TARGET IN HR-DEFICIENT CANCERS

#3688
20190055562
2019-02-21

Methods and compositions using RNA interference for inhibition of KRAS

#3689
20190055560
2019-02-21

FATS AS A TARGET FOR TREATING TUMORS AND USES THEREOF

#3690
20190055558
2019-02-21

Nucleic acid conjugate

#3691
20190055556
2019-02-21

Targeting pleiotrophin signaling to limit high-grade glioma invasion

#3692
20190055555
2019-02-21

Polynucleotide nanoparticles for the modulation of gene expression and uses thereof

#3693
20190055551
2019-02-21

PRNA three-way junctions

#3694
20190054180
2019-02-21

Gene/carrier complex for preventing or treating inflammatory diseases

#3695
20190054141
2019-02-21

Molecular marker for cancer stem cell

#3696
20190048360
2019-02-14

Double strand RNA-mediated RNA interference through feeding detrimental to larval (gypsy moth)

#3697
20190048352
2019-02-14

Compositions and methods for inhibiting expression of CD274/PD-L1 gene

#3698
20190048345
2019-02-14

Post-transcriptionally chemically modified double strand RNAs

#3699
20190048344
2019-02-14

CHEMICAL MODIFICATIONS OF MONOMERS AND OLIGONUCLEOTIDES WITH CYCLOADDITION

#3700
20190048342
2019-02-14

CROSS-REGULATION OF TYPE I INTERFERON SIGNALING PATHWAYS

#3701
20190048341
2019-02-14

Reduced size self-delivering nucleic acid compounds targeting long non-coding RNA

#3702
20190048339
2019-02-14

Methods for reactivating genes on the inactive X chromosome

#3703
20190048320
2019-02-14

Method for promoting differentiation of pluripotent stem cells by reducing undifferentiated state thereof

#3704
20190048139
2019-02-14

Biodegradable cationic polymers and uses thereof

#3705
20190046633
2019-02-14

Method of producing cells resistant to HIV infection

#3706
20190046443
2019-02-14

Liposomes for modulating Wiskott-Aldrich syndrome protein

#3707
20190040435
2019-02-07

Decreasing lactate level and increasing polypeptide production by down regulating the expression of lactate dehydrogenase and pyruvate dehydrogenase kinase

#3708
20190040394
2019-02-07

TREATMENT OF GLIAL CELL DERIVED NEUROTROPHIC FACTOR (GDNF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO GDNF

#3709
20190040389
2019-02-07

Post-transcriptionally chemically modified double strand RNAs

#3710
20190040388
2019-02-07

HIPPO AND DYSTROPHIN COMPLEX SIGNALING IN CARDIOMYOCYTE RENEWAL

#3711
20190040385
2019-02-07

Double-stranded oligonucleotide molecules targeting p53 and methods of use thereof

#3712
20190040122
2019-02-07

BIOLOGICAL MATERIALS AND USES THEREOF

#3713
20190038658
2019-02-07

High density lipoprotein binding protein (Hdlbp/Vigilin) iRNA compositions and methods of use thereof

#3714
20190038557
2019-02-07

MEANS FOR LUNG SPECIFIC DELIVERY

#3715
20190038538
2019-02-07

RNA complexes that inhibit melanin production

#3716
20190037854
2019-02-07

RNA interference for control of insect pests

#3717
20190032141
2019-01-31

High performance multi-input microRNA sensors and uses thereof

#3718
20190032087
2019-01-31

NUCLEIC ACID-CONTAINING LIPID PARTICLES AND RELATED METHODS

#3719
20190032085
2019-01-31

Process for mixing nucleic acids with transfection reagents for delivery

#3720
20190032061
2019-01-31

RNAi-Mediated Inhibition of Tumor Necrosis Factor Alpha-Related Conditions

#3721
20190032058
2019-01-31

Inhibition of oxidative stress in atrial fibrillation

#3722
20190032055
2019-01-31

Targeting glioblastoma stem cells through the TLX-TET3 axis

#3723
20190032054
2019-01-31

RNA cleavage-induced transcript stabilizer and uses thereof

#3724
20190032051
2019-01-31

NON-LIPOSOMAL SYSTEMS FOR NUCLEIC ACID DELIVERY

#3725
20190032050
2019-01-31

RNA nanoparticle for treatment of gastric cancer

#3726
20190031775
2019-01-31

Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities

#3727
20190031751
2019-01-31

EGFL6 specific monoclonal antibodies and methods of their use

#3728
20190030187
2019-01-31

Sirna/nanoparticle formulations for treatment of middle-east respiratory syndrome coronaviral infection

#3729
20190030158
2019-01-31

Means and methods for treating HBV

#3730
20190030120
2019-01-31

TIFA antagonists and their use for treating diseases

#3731
20190025307
2019-01-24

Methods to identify and treat subjects having corticosteroid-resistant inflammatory diseases

#3732
20190024112
2019-01-24

PARENTAL RNAI SUPPRESSION OF KRUPPEL GENE TO CONTROL HEMIPTERAN PESTS

#3733
20190024091
2019-01-24

CCR3 MODULATION IN THE TREATMENT OF AGING-ASSOCIATED IMPAIRMENTS, AND COMPOSITIONS FOR PRACTICING THE SAME

#3734
20190024090
2019-01-24

Construct for epigenetic modification and its use in the silencing of genes

#3735
20190024089
2019-01-24

Interfering RNA molecules

#3736
20190024086
2019-01-24

Methods and compositions for modulating gene expression

#3737
20190024085
2019-01-24

RNA ligand-displaying exosomes for specific delivery of therapeutics to cell by RNA nanotechnology

#3738
20190024084
2019-01-24

Treatment of filaggrin (FLG) related diseases by modulation of FLG expression and activity

#3739
20190024082
2019-01-24

Two-tailed self-delivering siRNA

#3740
20190024081
2019-01-24

Nucleic acid molecule, expression cassette, expression vector, eukaryotic host cell, induction method of RNA interference in eukaryotic host and use of the nucleic acid molecule in therapy of diseases induced by expansion of trinucleotide CAG repeats

#3741
20190024080
2019-01-24

Methods and compositions for inhibiting detoxification response

#3742
20190023783
2019-01-24

METHOD OF TREATING CANCER

#3743
20190023781
2019-01-24

THERAPEUTIC DRUG FOR MALIGNANT TUMORS

#3744
20190022225
2019-01-24

PROTOCOL FOR INCREASING LIFE EXPECTANCY IN A TEST SUBJECT

#3745
20190022125
2019-01-24

Methods and compositions for increasing the suppressive function of regulatory T-cells (Tregs)

#3746
20190022124
2019-01-24

Reagents for treatment of hepatitis B virus (HBV) infection and use thereof

#3747
20190022097
2019-01-24

MOLECULAR TARGETS FOR THE TREATMENT OF WOUNDS, IN PARTICULAR CHRONIC WOUNDS

#3748
20190017073
2019-01-17

COMPOSITIONS AND METHODS FOR DELIVERING NUCLEIC ACID TO A CELL

#3749
20190017054
2019-01-17

METHOD OF MODULATING SURVIVAL AND STEMNESS OF CANCER STEM CELLS BY MDA-9/SYNTENIN (SDCBP)

#3750
20190017053
2019-01-17

Treatment using truncated Trk B and Trk C antagonists

#3751
20190017051
2019-01-17

Oligonucleotide compositions with enhanced efficiency

#3752
20190017050
2019-01-17

Engineered immunostimulatory bacterial strains and uses thereof

#3753
20190017049
2019-01-17

Methods and compositions to inhibit metastasis and to treat fibrosis and to enhance wound healing

#3754
20190017047
2019-01-17

Methods for modulating Ataxin 2 expression

#3755
20190016751
2019-01-17

Compositions and methods directed to treating liver fibrosis

#3756
20190015442
2019-01-17

Dual molecular delivery of oligonucleotides and peptide containing conjugates

#3757
20190015422
2019-01-17

Methods for treating brain metastases using combinations of anti-P13K and anti-mTOR agents

#3758
20190015416
2019-01-17

BTK INHIBITORS FOR TREATING NEUROBLASTOMA

#3759
20190015330
2019-01-17

Liposomes comprising a calcium phosphate-containing precipitate

#3760
20190010548
2019-01-10

Methods and materials for determining pain sensitivity and predicting and treating related disorders

#3761
20190010520
2019-01-10

METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION

#3762
20190010502
2019-01-10

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF MUTANT EGFR GENE

#3763
20190010501
2019-01-10

Targeting WSB1 and pVHL to treat cancer

#3764
20190010500
2019-01-10

PREVENTIVE OR THERAPEUTIC AGENT FOR FIBROSIS

#3765
20190010497
2019-01-10

RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA)

#3766
20190010494
2019-01-10

RNAi agents for inhibiting expression of alpha-ENaC and methods of use

#3767
20190010493
2019-01-10

Treatment of heart disease by inhibtion of the action of muscle A-kinase anchoring protein (mAKAP)

#3768
20190010492
2019-01-10

Monocarboxylate transporter 4 (MCT) antisense oligonucleotide (ASO) inhibitors for use as therapeutics in the treatment of cancer

#3769
20190008976
2019-01-10

Compounds and methods for trans-membrane delivery of molecules

#3770
20190008898
2019-01-10

Inhibition of Diacylglycerol Kinase to Augment Adoptive T cell Transfer

#3771
20190004053
2019-01-03

Methods of detecting and reducing cancer cell central nervous system colonization

#3772
20190002991
2019-01-03

Method for diagnosing and treating ovarian cancer

#3773
20190002923
2019-01-03

METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION

#3774
20190002922
2019-01-03

METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION

#3775
20190002921
2019-01-03

METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION

#3776
20190002888
2019-01-03

FLT3 receptor antagonists for the treatment or the prevention of pain disorders

#3777
20190002885
2019-01-03

Anti-ADAM33 oligonucleotides and related methods

#3778
20190002884
2019-01-03

Methods of treating cancer by inhibition of DNA repair proteins using antisense based therapies

#3779
20190002883
2019-01-03

Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell

#3780
20190002881
2019-01-03

RNA-interference-inducing nucleic acid molecule able to penetrate into cells, and use therefor

#3781
20190002880
2019-01-03

DOUBLE-STRANDED OLIGONUCLEOTIDES

#3782
20190002879
2019-01-03

Methods and compositions for the specific inhibition of β-catenin by double-stranded RNA

#3783
20190002876
2019-01-03

COMPOSITIONS AND METHODS FOR TREATMENT OF FRIEDREICH'S ATAXIA

#3784
20190002868
2019-01-03

In vitro cleavage of DNA using argonaute

#3785
20190002569
2019-01-03

Methods and pharmaceutical compositions for the treatment of diseases mediated by the NRP-1/OBR complex signaling pathway

#3786
20190002553
2019-01-03

Treatment of fibrosis with interleukin-11 antibody

#3787
20190002499
2019-01-03

Peptides and nanoparticles for intracellular delivery of molecules

#3788
20190000990
2019-01-03

Carrier nanoparticles and related compositions, methods and systems

#3789
20190000987
2019-01-03

Nucleic acid-polypeptide compositions and uses thereof

#3790
20180371482
2018-12-27

Polypeptides having beta-xylosidase activity and polynucleotides encoding same

#3791
20180371466
2018-12-27

USE OF MCOLN-1 MODULATORS TO REGULATE CELL MIGRATION

#3792
20180371464
2018-12-27

RNA interference in dermal and fibrotic indications

#3793
20180371463
2018-12-27

Compositions and agents against hepatitis B virus and uses thereof

#3794
20180371459
2018-12-27

Compositions and methods for controlling arthropod parasite and pest infestations

#3795
20180371105
2018-12-27

Identification and use of new tumor-promoting gene in hematological malignancies

#3796
20180371102
2018-12-27

Nucleic acid-polypeptide compositions and uses thereof

#3797
20180371078
2018-12-27

Treatment of fibrosis with interleukin-11 receptor alpha antibody

#3798
20180371077
2018-12-27

Treatment of fibrosis with interleukin-11 receptor alpha antibody

#3799
20180371005
2018-12-27

Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom

#3800
20180369396
2018-12-27

Targeted sensitization of non-del(5q) malignant cells

#3801
20180369386
2018-12-27

Lipids and lipid compositions for the delivery of active agents

#3802
20180369282
2018-12-27

GENE-MODIFIED LYMPHOCYTES EXPRESSING CHIMERIC ANTIGEN RECEPTOR IN WHICH PRODUCTION OF INFLAMMATORY CYTOKINES IS INHIBITED

#3803
20180369142
2018-12-27

AMPHIPHILIC POLYMER MICELLES AND USES THEREOF

#3804
20180368422
2018-12-27

Methods and compositions of insect control

#3805
20180363008
2018-12-20

Methods and compositions to increase somatic cell nuclear transfer (SCNT) efficiency by removing histone H3-lysine trimethylation

#3806
20180362986
2018-12-20

INHIBITORS OF PLRG1 (PLEIOTROPIC REGULATOR 1) FOR PREVENTING OR TREATING CANCER AND METHODS FOR MAKING AND USING THEM

#3807
20180362985
2018-12-20

UNA oligomers having reduced off-target effects in gene silencing

#3808
20180362984
2018-12-20

Methods and compositions for managing vascular conditions

#3809
20180362978
2018-12-20

Compositions and Methods for Inhibition of Expression of Apolipoprotein C-III (APOC3) Genes

#3810
20180362977
2018-12-20

RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)

#3811
20180362658
2018-12-20

ESOPHAGEAL CANCER MARKER AND USE THEREOF

#3812
20180362641
2018-12-20

Treatment of fibrosis with interleukin-11 antibody

#3813
20180362640
2018-12-20

Treatment of fibrosis with interleukin-11 receptor alpha antibody

#3814
20180362639
2018-12-20

Treatment of fibrosis with IL-11 receptor alpha antibody

#3815
20180362638
2018-12-20

Treatment of fibrosis with Interleukin-11 receptor alpha antibody

#3816
20180362637
2018-12-20

Treatment of fibrosis with interleukin-11 receptor alpha antibody

#3817
20180362636
2018-12-20

Treatment of fibrosis with interleukin-11 antibody

#3818
20180362635
2018-12-20

Treatment of fibrosis with interleukin-11 antibody

#3819
20180362634
2018-12-20

Treatment of fibrosis with interleukin-11 antibody

#3820
20180362633
2018-12-20

Treatment of fibrosis with interleukin-11 antibody

#3821
20180362625
2018-12-20

REGULATION OF CYTOKINE PRODUCTION

#3822
20180360964
2018-12-20

PHARMACEUTICAL COMPOSITION AND A METHOD FOR PRODUCING THEREOF

#3823
20180360913
2018-12-20

Compositions and methods for modulating stem cells and uses thereof

#3824
20180360866
2018-12-20

MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes

#3825
20180360843
2018-12-20

MAO inhibitors and their conjugates as therapeutics for the treatment of brain cancer

#3826
20180360819
2018-12-20

ANTI-INFLUENZA VIRUS AGENT AND SCREENING METHOD FOR ANTI-INFLUENZA VIRUS AGENT

#3827
20180360797
2018-12-20

Treatment of tinnitus through modulation of chloride co-transporter NKCC1 in the auditory system

#3828
20180360030
2018-12-20

Methods and compositions for delivery of polynucleotides

#3829
20180355362
2018-12-13

Organic compositions to treat beta-ENaC-related diseases

#3830
20180355359
2018-12-13

METHODS FOR DETERMINING RESISTANCE TO ANTICANCER THERAPY AND COMPOSITION USED THEREFOR

#3831
20180355357
2018-12-13

Peptide, Complex of Peptide and siRNA, and Methods of Use Thereof

#3832
20180355352
2018-12-13

INHIBITING GENE EXPRESSION WITH dsRNA

#3833
20180355016
2018-12-13

Method of treating autoimmune disease with lymphocyte antigen CD5-like (CD5L) protein

#3834
20180353607
2018-12-13

LIPIDS FOR DELIVERY OF THERAPEUTICS

#3835
20180353435
2018-12-13

POLYMER-LIPID MATERIALS FOR DELIVERY OF NUCLEIC ACIDS

#3836
20180353434
2018-12-13

Nucleic acid-containing lipid nanoparticles

#3837
20180348240
2018-12-06

ApoCIII and the Treatment and Diagnosis of Diabetes

#3838
20180348224
2018-12-06

TENASCIN-W AND BILIARY TRACT CANCERS

#3839
20180346989
2018-12-06

METHODS OF DIAGNOSING AND TREATING BREAST CANCER

#3840
20180346915
2018-12-06

Pharmaceutical composition for inhibition of cancer cell metastasis including siRNA for ribosomal protein S3

#3841
20180346913
2018-12-06

Chemically modified multifunctional short interfering nucleic acid molecules that mediate RNA interference

#3842
20180346910
2018-12-06

Serpina1 iRNA compositions and methods of use thereof

#3843
20180346909
2018-12-06

System and method for reversible photo-controlled gene silencing

#3844
20180346908
2018-12-06

POLYNUCLEOTIDES FOR MULTIVALENT RNA INTERFERENCE, COMPOSITIONS AND METHODS OF USE THEREOF

#3845
20180344643
2018-12-06

Delivery method of target material into extracellular vesicles using extracorporeal shockwave

#3846
20180340177
2018-11-29

siRNA and their use in methods and compositions for inhibiting the expression of the NRARP gene

#3847
20180340154
2018-11-29

Production of viruses in avian eggs

#3848
20180338919
2018-11-29

AMPHOTERIC LIPOSOMES COMPRISING IMINO LIPIDS

#3849
20180334686
2018-11-22

Tissue selective transgene expression

#3850
20180334683
2018-11-22

STRUCTURE SPECIFIC RECOGNITION PROTEIN 1 (SSRP1) NUCLEIC ACID MOLECULES TO CONTROL INSECT PESTS

#3851
20180334678
2018-11-22

Treatment of C9FTD/ALS by targeting RNA expanded repeat sequences

#3852
20180334675
2018-11-22

Culicinae Mosquito TRA-2 RNA Interference Technique to Genetically Produce Maleness Population

#3853
20180334674
2018-11-22

Antitumor drug delivery formulation

#3854
20180334673
2018-11-22

CELL PENETRATING MOLECULE

#3855
20180327801
2018-11-15

METHOD FOR PREPARING RECOMBINANT PROTEINS THROUGH REDUCTION OF rnpA GENE EXPRESSION

#3856
20180327765
2018-11-15

Guayule with increased rubber production and yield

#3857
20180327755
2018-11-15

Treatment of age-related macular degeneration using RNA complexes that target MyD88 or TLR3

#3858
20180327754
2018-11-15

Modulation of CCR10 signals for treatment of skin and intestinal inflammatory diseases and infection

#3859
20180327753
2018-11-15

Means and methods for reducing tumorigenicity of cancer stem cells

#3860
20180327752
2018-11-15

Methods and compositions for modulating AAV infection

#3861
20180327751
2018-11-15

siRNA compositions that specifically downregulate expression of a variant of the PNPLA3 gene and methods of use thereof for treating a chronic liver disease or alcoholic liver disease (ALD)

#3862
20180327750
2018-11-15

Methods and compositions for reducing immunosupression by tumor cells

#3863
20180327748
2018-11-15

RNA interference in skin indications

#3864
20180327745
2018-11-15

METHODS OF CONTROLLING CELL FATE AND CONSEQUENCES FOR DISEASE

#3865
20180327744
2018-11-15

iRNA agents with biocleavable tethers

#3866
20180327501
2018-11-15

Tumor-specific anti-EGFR antibody and application thereof

#3867
20180326094
2018-11-15

Composition for preventing or treating keloid or hypertrophic scars

#3868
20180326092
2018-11-15

Argonaute protein-double stranded RNA complexes and uses related thereto

#3869
20180326079
2018-11-15

Fatty acids and their use in conjugation to biomolecules

#3870
20180326029
2018-11-15

Modified natural killer cells and natural killer cell lines having increased cytotoxicity

#3871
20180325992
2018-11-15

MODULATION OF AXON DEGENERATION

#3872
20180325937
2018-11-15

Modulation of ciliogenesis

#3873
20180325820
2018-11-15

BIOCOMPATIBLE WATER-SOLUBLE POLYMERS INCLUDING SULFOXIDE FUNCTIONALITY

#3874
20180321255
2018-11-08

Soluble MANF in pancreatic beta-cell disorders

#3875
20180320198
2018-11-08

Methods and compositions for integration defective lentiviral vectors

#3876
20180320187
2018-11-08

Toxic RNAi active seed sequences for killing cancer cells

#3877
20180320185
2018-11-08

Methods relating to circulating tumor cell clusters and the treatment of cancer

#3878
20180320182
2018-11-08

Methods and Compositions for Selecting siRNA of Improved Functionality

#3879
20180320180
2018-11-08

AGE-RELATED MACULAR DEGENERATION TREATMENT

#3880
20180320179
2018-11-08

LANOSTEROL 14-ALPHA DEMETHYLASE (CYP51) NUCLEIC ACID MOLECULES THAT CONTROL PATHOGENS

#3881
20180320178
2018-11-08

Stem cell with suppressed SOCS and improved immunosuppressive ability and use thereof

#3882
20180320177
2018-11-08

COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIVER FIBROSIS

#3883
20180320176
2018-11-08

INTRATHECAL DELIVERY OF NUCLEIC ACID SEQUENCES ENCODING ABCD1 FOR TREATMENT OF ADRENOMYELONEUROPATHY

#3884
20180320155
2018-11-08

Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same

#3885
20180320132
2018-11-08

Agents and methods for treating and preventing seborrheic keratosis

#3886
20180318448
2018-11-08

Method for determining presence or absence of suffering from malignant lymphoma or leukemia, and agent for treatment and/or prevention of leukemia

#3887
20180318428
2018-11-08

POLYAMINATED POLYGLUTAMIC ACID-CONTAINING COMPOUNDS AND USES THEREOF FOR DELIVERING OLIGONUCLEOTIDES

#3888
20180318396
2018-11-08

Methods of treating or preventing pruritis by blocking natriuretic polypeptide b

#3889
20180318330
2018-11-08

Compounds and methods for modulating C90RF72

#3890
20180314794
2018-11-01

Mantle phenotype detection in palm

#3891
20180313841
2018-11-01

Ovary Tumor Markers And Methods Of Use Thereof

#3892
20180312929
2018-11-01

Methods and compositions related to T-cell activity

#3893
20180312876
2018-11-01

Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

#3894
20180312875
2018-11-01

Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

#3895
20180312874
2018-11-01

Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

#3896
20180312844
2018-11-01

TREATMENT FOR CANCER METASTASIS

#3897
20180312809
2018-11-01

Agents and methods to elicit anti-tumor immune response

#3898
20180312607
2018-11-01

Application of PCSK9 inhibitors in the preparation of drugs for the treatment of inflammatory immune diseases

#3899
20180312557
2018-11-01

Leg1 Protein, Leg1 Gene, and Uses and Drugs thereof

#3900
20180312477
2018-11-01

Substituted thiazoles for preventing and/or treating cell or tissue necrosis